STRUCTURE OF F&S HOLDING
Farmaceutici CABER S.r.l. is a company controlled by the Group’s parent company F&S Holding S.r.l., a company whose share capital is entirely Italian. The Group, composed of four companies, operates in the pharmaceutical field, covering the following areas: from development to production, distribution, and scientific information to the medical class.
HISTORY
Farmaceutici CABER was born in Ravenna in 1945 and in the following years the headquarter was moved to Pisa first, then in Comacchio and finally in Pomezia (province of Rome) where it is actually located.
Over the years this company has consolidated its presence in the national pharmaceutical context, employing up to 130 persons, both employees and external collaborators. At headquarters marketing strategies are prepared and built up, commercial sales plans are checked and continuous training of external collaborators, who take care of the Scientific Information activity to the medical class all over the national territory, is performed.
MISSION and VALUES
Farmaceutici CABER’s mission is to answer the more and more growing request of health and welfare arriving from society.
We pursue this objective with motivation, enthusiasm and a strong sense of responsibility towards the real needs of our partners, either patients, healthcare professionals, distributors or institutions.
The service to the scientific community in general and the contribution to the medical class continuous education in particular, through the scientific information, represent the fundamental values by which Farmaceutici CABER, through a behavior inspired by ethical principles, intends to keep and improve its own image of a Company always close to physicians, pharmacists and all healthcare operators.
In such a complex and continuously changing context as the pharmaceutical one, improving one’s image means ensuring a higher credibility and reliability.
Farmaceutici CABER, well aware of the high social and ethical responsibility profile it is requested for, pursues such goal drawing inspiration from some principles deemed essential, which are:
• Credibility of information, always documented
• Closest cooperation with healthcare operators
• Relationships with healthcare operators always inspired by principles of ethics and transparency
The company’s Administrative Body has adopted the Code of Conduct of F&S Holding S.r.l.
the Code of Conduct also represents a governance instrument and is an integral part of the Company’s “Model of Organisation, Management and Control” for the protection from incriminations according to Legislative Decree n. 231/2001 with reference to the Company’s administrative responsibilities.
ETHICS and TRANSPARENCY
Farmaceutici CABER, being aware to play a role in the creation of a more and more modern Health system for the benefit of Citizens’ health, models its conduct on principles of ethics and transparency
Farmaceutici CABER deems it essential to establish an ethic, loyal and transparent relationship with its counterparts, either Healthcare operators, Institutions, Citizens, Collaborators or commercial Partners. On this basis, the Company operates in accordance with current rules and regulations, professional ethics and internal policies. Even if it is not a member of Farmindustria, Farmaceutici CABER operates in accordance with the current rules and regulations, professional ethics, internal policies and Code of Conduct of this association. Based on the ethical principles driving its actions and in order to satisfy the more and more pressing and continuous expectations of legality and transparency expressed by both Citizens and Institutions, Farmaceutici CABER has adhered with conviction to the EFPIA Code (European Federation of Pharmaceutical Industries and Associations), whose contents have been included in the Code of Conduct of Farmindustria.
The correct and positive relationship established between Pharmaceutical Industry and Healthcare Professionals (HCP: Healthcare Professionals) and/or Healthcare Organisations (HCO: Heathcare Organisations) has always lead to research and develop innovative therapies, aimed at safeguarding one of the fundamental and constitutionally guaranteed Citizens’ rights, i.e. the right to health.
In fact, it is useful to highlight that the Transfers of Value between the pharmaceutical
Industry and the medical Community, which the EFPIA Code refers to, cannot and should not be exclusively considered as transfers of economic nature; they also convey the mutual transfer of a much important value, i.e. the scientific knowledge, for the benefit of Citizens/Patients. The cooperation between pharmaceutical Industry, healthcare Operators and healthcare Organisations, already well regulated by the current legislation, becomes even more transparent thanks to the application of the EFPIA Code. Such further transparency in relationships shall consolidate the basis for the future collaborations and lead to further benefits for Citizens/Patients that, having the opportunity to know the contents of such relationships, shall be in the condition to receive the proposed treatments with greater trust and awareness. The Transfers of Value, which data publication is requested for, are those relative to the participation to Events (Conventions, Congresses, Visits to production plants…), consulting and professional services, donations and contributions, research and development (clinical, non-clinical and
For year 2020, please see the relative TABLE
For year 2021, please see the relative TABLE
For year 2022, please see the relative TABLE